Countries covered: United States
Introduction:
The US market for nonvascular interventional radiology devices, comprising disposable radiofrequency (RF) ablation and cryoablation devices for liver, kidney, and lung cancer treatment, percutaneous drainage catheters, and soft tissue biopsy needles, was valued at just under $230 million in 2010. Revenue growth will be sustained primarily by the rising incidence of conditions for which ablation devices, drainage catheters, and biopsy needles are used for treatment or diagnosis-a trend supported by the aging US population-and the increasing preference for minimally invasive procedures over the forecast period. This will in turn be encouraged by the benefits of minimally invasive techniques-including shorter recovery times and reduced patient complications of surgery-and the release of clinical research supporting the efficacy of these treatments. Although the strong presence of group purchasing organizations (GPOs) will apply downward pressure on average selling prices (ASPs), relatively few competitors are active in the US RF ablation and cryoablation device segments, rendering them resistant to significant price erosion. As a result, this market will experience rapid expansion through 2015.
Questions Answered in This Report:
- Cryoablation and microwave ablation are two ablation techniques that compete with RF ablation for the treatment of kidney, liver, and lung cancer. What factors are driving the adoption of cryoablation and microwave ablation? How will the growth of RF ablation be affected by the presence of these alternative ablation techniques?
- According to US interventional radiologists surveyed in this report, alternative ablation techniques to RF ablation are currently being adopted in clinical practice for the treatment of kidney, liver, and lung cancers. While clinical studies such as the RAPTURE (Radiofrequency Ablation of Pulmonary Tumors Response Evaluation) study have demonstrated the efficacy of RF ablation, physicians continue to await research that evaluates the long-term efficacy and safety of cryoablation and microwave ablation in comparison to RF ablation. Which alternative ablation technologies are interventional radiologists adopting? What are the perceptions physicians have of these new ablation technologies in the US? For the treatment of which cancer types will alternative ablation technologies be adopted?
- GPOs play a key role in negotiating purchasing contracts with vendors-both manufacturers and distributors-to obtain the best discounted savings for high-volume products, such as percutaneous drainage catheters, for hospitals. How will GPOs impact ASPs in the percutaneous drainage catheter market? What strategies are medical device companies exploring to expand their market penetration?
- Core needle biopsy and fine needle biopsy are two types of procedures using percutaneous soft tissue biopsy needles used to assist physicians in diagnosing patients with cancer. How will the use of vacuum-assisted biopsies impact core needle biopsy and fine needle biopsy procedure volumes with the rising incidence of cancer?
Scope:
Regions covered: US
Procedure and market segmentation: Our analysis uses the following breakdown of procedures and the market:
- RF ablation devices
- Kidney cancer (primary and secondary)
- Liver cancer (primary and secondary)
- Lung cancer (primary and secondary)
- Cryoablation devices
- Kidney cancer (primary and secondary)
- Liver cancer (primary and secondary)
- Lung cancer (primary and secondary)
- Percutaneous drainage catheters
- General
- Nephrostomy
- Biliary
- Soft tissue biopsy needles
- Core needles
- Fine needles
Market forecast features: Based on primary research with industry professionals and key opinion leaders in the interventional radiology profession, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 7-year period (2009-2015).
Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.
|
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 US NONVASCULAR INTERVENTIONAL RADIOLOGY DEVICE MARKET
- 1.1 Market Overview
- 1.2 Market Analysis
- 1.2.1 Key Report Updates
- 1.2.2 Indication Overview
- 1.2.2.1 Kidney Cancer
- 1.2.2.2 Liver Cancer
- 1.2.2.3 Lung Cancer
- 1.2.3 Procedures
- 1.2.4 Market Forecast
- 1.3 Competitive Analysis
- 2.0 RADIOFREQUENCY ABLATION DEVICE MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Procedures
- 2.2.1.1 Kidney Cancer RF Ablation Procedures
- 2.2.1.2 Liver Cancer RF Ablation Procedures
- 2.2.1.3 Lung Cancer RF Ablation Procedures
- 2.2.2 Market Forecast
- 2.2.3 Market Drivers and Limiters
- 2.2.3.1 Market Drivers
- 2.2.3.2 Market Limiters
- 2.3 Competitive Analysis
- 2.3.1 Competitive Landscape
- 2.3.2 Market Shares
- 2.3.3 Competitor Discussions (in Alphabetical Order)
- 2.3.3.1 Leading Competitors
- AngioDynamics
- Boston Scientific
- Covidien
- 2.3.3.2 Emerging Competitors
- Celsion Corporation
- HS Medical
- 3.0 CRYOABLATION DEVICE MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures
- 3.2.1.1 Kidney Cancer Cryoablation Procedures
- 3.2.1.2 Liver Cancer Cryoablation Procedures
- 3.2.1.3 Lung Cancer Cryoablation Procedures
- 3.2.2 Market Forecast
- 3.2.3 Market Drivers and Limiters
- 3.2.3.1 Market Drivers
- 3.2.3.2 Market Limiters
- 3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.2 Market Shares
- 3.3.3 Competitor Discussions (in Alphabetical Order)
- Galil Medical
- HealthTronics (acquired by Endo Pharmaceuticals)
- 4.0 PERCUTANEOUS DRAINAGE CATHETER MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures
- 4.2.2 Market Forecast
- 4.2.3 Market Drivers and Limiters
- 4.2.3.1 Market Drivers
- 4.2.3.2 Market Limiters
- 4.3 Competitive Analysis
- 4.3.1 Competitive Landscape
- 4.3.2 Market Shares
- 4.3.3 Competitor Discussions (in Alphabetical Order)
- AngioDynamics
- Angiotech
- Boston Scientific
- Cook Medical
- C. R. Bard
- Merit Medical Systems
- Teleflex Medical
- UreSil
- 5.0 SOFT TISSUE BIOPSY NEEDLE MARKET
- 5.1 Market Overview
- 5.2 Market Analysis
- 5.2.1 Procedures
- 5.2.2 Market Forecast
- 5.2.3 Market Drivers and Limiters
- 5.2.3.1 Market Drivers
- 5.2.3.2 Market Limiters
- 5.3 Competitive Analysis
- 5.3.1 Competitive Landscape
- 5.3.2 Competitor Discussions (in Alphabetical Order)
- Angiotech
- Boston Scientific
- Cardinal Health
- Cook Medical
- C. R. Bard
- Other
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- APPENDIX B: SUPPLEMENTAL FIGURES
- LIST OF FIGURES AND TABLES
- EXECUTIVE SUMMARY
- Figure 1: Nonvascular Interventional Radiology Device Market, US (US$), 2009-2015
- Figure 2: RF Ablation Device Market, by Cancer Type, as a % of Total, US, 2010 and 2015
- Figure 3: Cryoablation Device Market, by Cancer Type, as a % of Total, US, 2010 and 2015
- Figure 4: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009-2015
- Figure 5: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009-2015
- Table 1: Companies Mentioned in This Report
- METHODOLOGY
- 1.0 US NONVASCULAR INTERVENTIONAL RADIOLOGY DEVICE MARKET
- Figure 6: Nonvascular Interventional Radiology Device Market, by Segment, US (US$), 2009-2015
- Table 2: Key Report Updates, 2011
- Table 3 Incidence of Primary-Origin Renal Cell Carcinoma, by Tumor Status, US, 2009-2015
- Table 4 Incidence of Primary-Origin Hepatocellular Carcinoma, by Tumor Status, US, 2009-2015
- Table 5 Incidence of Primary-Origin Non-Small-Cell Lung Cancer, by Tumor Status, US, 2009-2015
- Table 6: Nonvascular Interventional Radiology Procedures, by Segment, US, 2009-2015
- Table 7: Nonvascular Interventional Radiology Device Market, by Segment, US (US$), 2009-2015
- Table 8: Competitors in the Nonvascular Interventional Radiology Device Market, US, 2010
- 2.0 RADIOFREQUENCY ABLATION DEVICE MARKET
- Figure 7: RF Ablation Device Market, by Cancer Type, US (US$), 2009-2015
- Table 9: RF Ablation Procedures, by Cancer Type, US, 2009-2015
- Table 10: Kidney Cancer RF Ablation Procedures, by Origin of Cancer, US, 2009-2015
- Table 11: Liver Cancer RF Ablation Procedures, by Origin of Cancer, US, 2009-2015
- Table 12: Lung Cancer RF Ablation Procedures, by Origin of Cancer, US, 2009-2015
- Table 13: RF Ablation Device Market, by Cancer Type, US (US$), 2009-2015
- Table 14: RF Ablation Device Market Growth, by Cancer Type, US, 2010-2015
- Table 15: RF Ablation Device Market, by Cancer Type, as a % of Total, US, 2009-2015
- Table 16: Kidney Cancer RF Ablation Device Market, by Origin of Cancer, US (US$), 2009-2015
- Table 17: Liver Cancer RF Ablation Device Market, by Origin of Cancer, US (US$), 2009-2015
- Table 18: Lung Cancer RF Ablation Device Market, by Origin of Cancer, US (US$), 2009-2015
- Table 19: Drivers and Limiters of the RF Ablation Device Market, US
- Table 20: Leading Competitors in the RF Ablation Device Market, as a % of Total, US, 2010
- 3.0 CRYOABLATION DEVICE MARKET
- Figure 8: Cryoablation Device Market, by Cancer Type, US (US$), 2009-2015
- Table 21: Cryoablation Procedures, by Cancer Type, US, 2009-2015
- Table 22: Kidney Cancer Cryoablation Procedures, by Origin of Cancer, US, 2009-2015
- Table 23: Liver Cancer Cryoablation Procedures, by Origin of Cancer, US, 2009-2015
- Table 24: Lung Cancer Cryoablation Procedures, by Origin of Cancer, US, 2009-2015
- Table 25: Cryoablation Device Market, by Cancer Type, US (US$), 2009-2015
- Table 26: Cryoablation Device Market Growth, by Cancer Type, US, 2010-2015
- Table 27: Cryoablation Device Market, by Cancer Type, as a % of Total, US, 2009-2015
- Table 28: Kidney Cryoablation Device Market, by Origin of Cancer, US (US$), 2009-2015
- Table 29: Liver Cryoablation Device Market, by Origin of Cancer, US (US$), 2009-2015
- Table 30: Lung Cryoablation Device Market, by Origin of Cancer, US (US$), 2009-2015
- Table 31: Drivers and Limiters of the Cryoablation Device Market, US
- Table 32: Leading Competitors in the Cryoablation Device Market, as a % of Total, US, 2010
- 4.0 PERCUTANEOUS DRAINAGE CATHETER MARKET
- Figure 9: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009-2015
- Table 33: Percutaneous Drainage Catheter Procedures, by Type, US, 2009-2015
- Table 34: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009-2015
- Table 35: Percutaneous Drainage Catheter Market Growth, by Type, US, 2010-2015
- Table 36: Percutaneous Drainage Catheter Market, by Type, as a % of Total, US, 2009-2015
- Table 37: Drivers and Limiters of the Percutaneous Drainage Catheter Market, US
- Table 38: Leading Competitors in the Drainage Catheter Market, as a % of Total, US, 2010
- 5.0 SOFT TISSUE BIOPSY NEEDLE MARKET
- Figure 10: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009-2015
- Table 39: Soft Tissue Biopsy Needle Procedures, by Type, US, 2009-2015
- Table 40: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009-2015
- Table 41: Soft Tissue Biopsy Needle Market Growth, by Segment, US, 2010-2015
- Table 42: Soft Tissue Biopsy Needle Market, by Segment, as a % of Total, US, 2009-2015
- Table 43: Drivers and Limiters of the Soft Tissue Biopsy Needle Market, US
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
- APPENDIX B: SUPPLEMENTAL FIGURES
- Figure 11: Nonvascular Interventional Radiology Device Market, US (US$), 2009-2015 (Detailed Format)
- Figure 12: RF Ablation Device Market, by Cancer Type, as a % of Total, US, 2010 and 2015 (Detailed Format)
- Figure 13: Cryoablation Device Market, by Cancer Type, as a % of Total, US, 2010 and 2015 (Detailed Format)
- Figure 14: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009-2015 (Detailed Format)
- Figure 15: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009-2015 (Detailed Format)
More United States Interventional Radiology Reports
U.S. Brachytherapy Market by
Frost & Sullivan
This research service looks at the seeds brachytherapy market.
...
The U.S. Market for Interventional Radiology Products by
Kalorama Information
Changing demographics are spurring dynamic growth in the interventional radiology market. The angioplasty balloon, coronary stent, vascular closure, and other associated equipment markets will ...
U.S. CSF Management and Interventional Neuroradiology Markets by
Frost & Sullivan
Potential Revenue Growth Attracts Competition
Competition is increasing in the cerebrospinal fluid (CSF) management and
interventional neuroradiology markets with the advent of new products and
...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Share this report
Other tasks Related Markets Interventional Radiology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
